Long-Term Outcomes of Holmium Laser Enucleation of the Prostate: A 5-Year Single-Center Experience
Authors:
- Dmitry EnikeevDEDmitry Enikeev
- Mark Sergeevich TaratkinMTMark Sergeevich Taratkin
- Andrey MorozovAMAndrey Morozov
- Nirmish SinglaNSNirmish Singla
- Roman Borisovich SukhanovRSRoman Borisovich Sukhanov
- Juan Gomez RivasJRJuan Gomez Rivas
- Ekaterina LaukhtinaELEkaterina Laukhtina
- Magomed ArshievMAMagomed Arshiev
- Petr Vitalievich GlybochkoPGPetr Vitalievich Glybochko
- 1 October 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 34 (10) , 1055-1063
Abstract
Objective: To analyze the long-term efficacy and safety of holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia. Materials and Methods: A total of 127 patients who underwent HoLEP at our institution between 2013 and 2015 were included. Patients were observed for 5 years postoperatively. We evaluated the length of the surgery, the mass of the removed tissue, prostate-specific antigen level, the maximal flow rate (Qmax), postvoid residual (PVR), the length of catheterization and hospitalization, and the International Prostate Symptom Score (IPSS) and IPSS quality of life (QoL) at each clinic visit. Results: PVR, Qmax, IPSS, and QoL all improved significantly immediately after the operation ( p < 0.001). By the end of the 5th postoperative year, all the parameters showed a statistically meaningful decline: Qmax reduced by 5.8 mL/s (22.6%) and IPSS by 1.4 points (29.1%). Around 8.6% of the patients continued therapy with α-blockers. There were no differences in efficacy by the age of the patients or the volume of the prostate. Long-term complications and need for repeat operations were not affected by the volume of the prostate or patient age. Conclusions: The improvement of PVR, Qmax, IPSS, and QoL score seen in the early postoperative period after performing HoLEP remains evident at 5 years postoperatively. Long-term complications and the need for reoperation do not depend on the age of the patient or on the initial volume of the prostate.Keywords
This publication has 16 references indexed in Scilit:
- Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaUrology, 2015
- Reoperation After Holmium Laser Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: Assessment of Risk Factors with Time to Event AnalysisJournal of Endourology, 2015
- A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An UpdateEuropean Urology, 2015
- Factors Associated With Continuing Medical Therapy After Transurethral Resection of ProstateUrology, 2014
- A Prospective, Randomized Clinical Trial Comparing Plasmakinetic Resection of the Prostate with Holmium Laser Enucleation of the Prostate Based on a 2-Year FollowupJournal of Urology, 2013
- Holmium Laser Enucleation of the Prostate: A Modified Enucleation Technique and Initial ResultsJournal of Urology, 2012
- Long‐term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 yearsBJU International, 2011
- Experience With More Than 1,000 Holmium Laser Prostate Enucleations for Benign Prostatic HyperplasiaJournal of Urology, 2010
- Holmium Laser Enucleation of the Prostate versus Open Prostatectomy for Prostates Greater than 100 Grams: 5-Year Follow-Up Results of a Randomised Clinical TrialEuropean Urology, 2008
- Holmium Laser Enucleation for Prostatic Adenoma: Analysis of Learning Curve Over the Course of 70 Consecutive CasesJournal of Urology, 2003